Jundishapur Journal of Microbiology

Published by: Kowsar

Nosocomial Yeast Infections Among Cancer Patients in Egypt: Species Distribution and Antifungal Susceptibility Profile

Noha Badr El-Din El-Mashad 1 , Amina Mostafa Abdel Aal 1 , Ahmad Mohamed Elewa 1 and Mohammed Youssef Saad Elshaer 1 , *
Authors Information
1 Clinical Pathology Department, Mansoura University, Mansoura, Egypt
Article information
  • Jundishapur Journal of Microbiology: 12 (2); e82421
  • Published Online: February 6, 2019
  • Article Type: Research Article
  • Received: July 20, 2018
  • Revised: January 8, 2019
  • Accepted: January 16, 2019
  • DOI: 10.5812/jjm.82421

To Cite: El-Mashad N B E, Abdel Aal A M, Elewa A M, Saad Elshaer M Y. Nosocomial Yeast Infections Among Cancer Patients in Egypt: Species Distribution and Antifungal Susceptibility Profile, Jundishapur J Microbiol. Online ahead of Print ; 12(2):e82421. doi: 10.5812/jjm.82421.

Abstract
Copyright © 2019, Author(s). This is an open-access article distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 International License (http://creativecommons.org/licenses/by-nc/4.0/) which permits copy and redistribute the material just in noncommercial usages, provided the original work is properly cited.
1. Background
2. Objectives
3. Methods
4. Results
5. Discussion
Acknowledgements
Footnotes
References
  • 1. Krishnan NS. Emerging fungal infections in cancer patients-a brief overview. Med Mycol Open Access. 2016;2:16. doi: 10.21767/2471-8521.100016.
  • 2. Alastruey-Izquierdo A, Melhem MS, Bonfietti LX, Rodriguez-Tudela JL. Susceptibility test for fungi: Clinical and laboratorial correlations in medical mycology. Rev Inst Med Trop Sao Paulo. 2015;57 Suppl 19:57-64. doi: 10.1590/S0036-46652015000700011. [PubMed: 26465371]. [PubMed Central: PMC4711191].
  • 3. McCarty TP, Pappas PG. Invasive Candidiasis. Infect Dis Clin North Am. 2016;30(1):103-24. doi: 10.1016/j.idc.2015.10.013. [PubMed: 26739610].
  • 4. Aydemir Ö, Demiray T, Köroglu M, Aydemir Y, Altindi M. Emerge of non-albicans Candida species; evaluation of Candida species and antifungal susceptibilities according to years. Biomedical Research. 2017;28(6).
  • 5. Liao Y, Lu X, Yang S, Luo Y, Chen Q, Yang R. Epidemiology and outcome of trichosporon fungemia: A review of 185 reported cases from 1975 to 2014. Open Forum Infect Dis. 2015;2(4):ofv141. doi: 10.1093/ofid/ofv141. [PubMed: 26566536]. [PubMed Central: PMC4630454].
  • 6. Miglietta F, Letizia Faneschi M, Braione A, Palumbo C, Rizzo A, Lobreglio G, et al. Central venous catheter-related fungemia caused by Rhodotorula glutinis. Med Mycol J. 2015;56(3):E17-9. doi: 10.3314/mmj.56.E17. [PubMed: 26329371].
  • 7. Alangaden GJ. Nosocomial fungal infections: Epidemiology, infection control, and prevention. Infect Dis Clin North Am. 2011;25(1):201-25. doi: 10.1016/j.idc.2010.11.003. [PubMed: 21316001].
  • 8. Singh GK, Capoor MR, Nair D, Bhowmik KT. Spectrum of fungal infection in head and neck cancer patients on chemoradiotherapy. J Egypt Natl Canc Inst. 2017;29(1):33-7. doi: 10.1016/j.jnci.2017.01.006. [PubMed: 28258917].
  • 9. Patolia S, Kennedy E, Zahir M, Patolia S, Gulati N, Narendra D, et al. Risk factors for candida blood stream infection in medical ICU and role of colonization-A retrospective study. Br J Med Pract. 2013;6(2):a618.
  • 10. Fisher BT, Robinson PD, Lehrnbecher T, Steinbach WJ, Zaoutis TE, Phillips B, et al. Risk factors for invasive fungal disease in pediatric cancer and hematopoietic stem cell transplantation: A systematic review. J Pediatric Infect Dis Soc. 2018;7(3):191-8. doi: 10.1093/jpids/pix030. [PubMed: 28549148].
  • 11. Sandhu R, Dahiya S, Sayal P, Budhani D. Increased role of nonalbicans Candida, potential risk factors, and attributable mortality in hospitalized patients. J Health Res Rev. 2017;4(2):78-83. doi: 10.4103/2394-2010.208115.
  • 12. Sardi JC, Scorzoni L, Bernardi T, Fusco-Almeida AM, Mendes Giannini MJ. Candida species: Current epidemiology, pathogenicity, biofilm formation, natural antifungal products and new therapeutic options. J Med Microbiol. 2013;62(Pt 1):10-24. doi: 10.1099/jmm.0.045054-0. [PubMed: 23180477].
  • 13. Zhang L, Zhou S, Pan A, Li J, Liu B. Surveillance of antifungal susceptibilities in clinical isolates of Candida species at 36 hospitals in China from 2009 to 2013. Int J Infect Dis. 2015;33:1-4. doi: 10.1016/j.ijid.2014.12.033. [PubMed: 25541294].
  • 14. Pahwa N, Kumar R, Nirkhiwale S, Bandi A. Species distribution and drug susceptibility of candida in clinical isolates from a tertiary care centre at Indore. Indian J Med Microbiol. 2014;32(1):44-8. doi: 10.4103/0255-0857.124300. [PubMed: 24399387].
  • 15. Kumari KS, Raghunath P, Harshavardhan B, Chaudhury A. Distribution of Candida albicans and the non-albicans Candida species in different clinical specimens from South India. Int J Microbiol Res. 2014;5:1-5. doi: 10.5829/idosi.ijmr.2014.5.1.8232.
  • 16. Montagna MT, Caggiano G, Lovero G, De Giglio O, Coretti C, Cuna T, et al. Epidemiology of invasive fungal infections in the intensive care unit: Results of a multicenter Italian survey (AURORA Project). Infection. 2013;41(3):645-53. doi: 10.1007/s15010-013-0432-0. [PubMed: 23463186]. [PubMed Central: PMC3671106].
  • 17. Ding X, Yan D, Sun W, Zeng Z, Su R, Su J. Epidemiology and risk factors for nosocomial non-Candida albicans candidemia in adult patients at a tertiary care hospital in North China. Med Mycol. 2015;53(7):684-90. doi: 10.1093/mmy/myv060. [PubMed: 26229153].
  • 18. Sharma Y, Chumber SK, Kaur M. Studying the prevalence, species distribution, and detection of in vitro production of phospholipase from candida isolated from cases of invasive candidiasis. J Glob Infect Dis. 2017;9(1):8-11. doi: 10.4103/0974-777X.199995. [PubMed: 28250619]. [PubMed Central: PMC5330047].
  • 19. Magalhaes YC, Bomfim MR, Melonio LC, Ribeiro PC, Cosme LM, Rhoden CR, et al. Clinical significance of the isolation of Candida species from hospitalized patients. Braz J Microbiol. 2015;46(1):117-23. doi: 10.1590/S1517-838246120120296. [PubMed: 26221096]. [PubMed Central: PMC4512074].
  • 20. Siqueira RA, Doi AM, de Petrus Crossara PP, Koga PCM, Marques AG, Nunes FG, et al. Evaluation of two commercial methods for the susceptibility testing of Candida species: Vitek 2((R)) and Sensititre YeastOne((R)). Rev Iberoam Micol. 2018;35(2):83-7. doi: 10.1016/j.riam.2017.11.001. [PubMed: 29580699].
  • 21. Marcos-Zambrano LJ, Puig-Asensio M, Perez-Garcia F, Escribano P, Sanchez-Carrillo C, Zaragoza O, et al. Candida guilliermondii complex is characterized by high antifungal resistance but low mortality in 22 cases of candidemia. Antimicrob Agents Chemother. 2017;61(7). doi: 10.1128/AAC.00099-17. [PubMed: 28438935]. [PubMed Central: PMC5487632].
  • 22. Pfaller MA, Diekema DJ, Gibbs DL, Newell VA, Ellis D, Tullio V, et al. Results from the ARTEMIS DISK Global Antifungal Surveillance Study, 1997 to 2007: A 10.5-year analysis of susceptibilities of Candida Species to fluconazole and voriconazole as determined by CLSI standardized disk diffusion. J Clin Microbiol. 2010;48(4):1366-77. doi: 10.1128/JCM.02117-09. [PubMed: 20164282]. [PubMed Central: PMC2849609].
  • 23. Czaika V, Nenoff P, Glockner A, Becker K, Fegeler W, Schmalreck AF. Detection of azole susceptibility patterns in clinical yeast strains isolated from 1998 to 2008. New Microbiol. 2014;37(4):465-94. [PubMed: 25387285].
  • 24. Perlin DS. Echinocandin Resistance in Candida. Clin Infect Dis. 2015;61 Suppl 6:S612-7. doi: 10.1093/cid/civ791. [PubMed: 26567278]. [PubMed Central: PMC4643482].

Featured Image:

Creative Commons License Except where otherwise noted, this work is licensed under Creative Commons Attribution Non Commercial 4.0 International License .

Search Relations:

Author(s):

Article(s):

Create Citiation Alert
via Google Reader

Readers' Comments